Last reviewed · How we verify

NCT06840171: Mandala

The Effect of Mandala Coloring on Depression, Anxiety and Quality of Life of Inpatients in a Psychiatric Clinic

Completed NA Last updated 30 September 2025
What this trial tests

NA trial testing Mandala coloring in Depression in 51 participants. Completed in 28 September 2025.

Timeline
22 February 2025
Primary endpoint
28 September 2025
28 September 2025

Quick facts

Lead sponsorreyhan eskiyurt
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment51
Start date22 February 2025
Primary completion28 September 2025
Estimated completion28 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

reyhan eskiyurt

Who can join

Adults 18 to 75, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the effects of mandala coloring activity applied to individuals hospitalized in a psychiatric clinic with a diagnosis of anxiety and depression disorder on quality of life, psychological resilience and depression, anxiety and stress levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mandala coloring

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06840171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing